Calcium beta-hydroxy-beta-methylbutyrate

We are Calcium beta-hydroxy-beta-methylbutyrate CAS:135236-72-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Product Name: Calcium beta-hydroxy-beta-methylbutyrate
Synonym: β-Hydroxy-β-methylbutyric acid calcium salt;Calcium β-hydroxy-β-methylbutyric acid;3-Hydroxyisovaleric acid calcium salt;HMB-Ca
Cas No.: 135236-72-5
Formula: C₁₀H₁₈CaO₆
MW: 274.32
EINECS No.:681-140-5
Boiling point: 242.8ºC at 760 mmHg
Flash point: 114.9ºC
HS Code: 2918190090

UN No.: 1992
Hazard class: 3 categories 
Packing level: Class II
 
Specification

Items of Analysis	Standard of Analysis	Test Results
Appearance	White crystalline powder	White crystalline powder
Assay	≥99.0%	101.6%
HMB Assay	≥84.0%	85.88%
Ca2+ Assay	13.5-15.5%	14.77%
Loss on drying	≤7.50%	4.09%
Heavy metals ,(Pb)	≤10ppm	<10ppm
As	≤1ppm	<1ppm
Total Aerobic	1000cfu/g max	<1000cfu/g
Mold and Yeast	100cfu/g max	<100cfu/g
E.COLI form	Non-detective	Non-detective
Salmonella	Non-detective	Non-detective
Conclusion	Conforms to Factory Standard

 
 
Application
Applicationd as pharmaceutical intermediates, feed additives, etc.
 
Packaging
25 kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 

Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.3-Fluoro-2-methylbenzaldehyde CAS:147624-13-3 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.4-hidroxibenzotioamida CAS:25984-63-8 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.5-Bromo-2-fluorobenzoic acid CAS:146328-85-0 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.